Breaking News Instant updates and real-time market news.

ORGS

Orgenesis

$4.28 /

-0.13 (-2.95%)

07:46
04/13/20
04/13
07:46
04/13/20
07:46

Orgenesis agrees to acquire assets of Tamir Biotechnology for approx. $19M

Orgenesis announces it has entered into an agreement to acquire the assets of Tamir Biotechnology, including ranpirnase, TamirBio's broad spectrum anti-viral platform. The acquisition will be completed for total stock and cash consideration valued at approximately $19M, based on the value of the stock at closing. Orgenesis plans to combine ranpirnase with its co-developed Bioxome technology for enhanced payload delivery directly to cells. TamirBio is a clinical stage anti-viral therapeutics company engaged in the discovery and development of a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions. TamirBio's lead asset, ranpirnase, a ribonuclease, is a member of the superfamily of enzymes that catalyze the degradation of RNA, and mediate several essential biological activities, including the regulation of cell proliferation, maturation, differentiation, and cell death. Therefore, it is a potential candidate for the development of therapeutics for life-threatening diseases, including viral and autoimmune diseases, that require anti-proliferative and apoptotic properties. TamirBio's first target is the human papilloma virus, the worldwide leading cause of genital warts. The company's lead asset, topical ranpirnase, was evaluated in a phase I/II clinical trial targeting genital warts. The phase I/II study demonstrated clear clinical effect of ranpirnase. Additional clinical trials are currently being planned. Orgenesis and TamirBio plan to combine ranpirnase with Bioxomes, which have demonstrated the ability to fuse with cell membranes and deliver an intracellular cargo, in a similar manner to natural exosomes. Bioxomes can carry selected therapeutic cargo inside the target cells when loaded with predesignated genetic material, proteins, signaling molecules and drugs, as these mimic the natural membrane fusion capacity of exosomes. Orgenesis and TamirBio believe the combination of the two platforms will result in enhanced efficacy and anti-viral results.

ORGS Orgenesis
$4.28 /

-0.13 (-2.95%)

09/26/19 Benchmark
Orgenesis initiated with a Speculative Buy at Benchmark

TODAY'S FREE FLY STORIES

Recommendations
Sage Therapeutics price target lowered to $74 from $81 at H.C. Wainwright » 06:07
12/01/20
12/01
06:07
12/01/20
06:07
SAGE

Sage Therapeutics

$74.09 /

-1.5 (-1.98%)

, BIIB

Biogen

$240.36 /

-3.61 (-1.48%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

11/30/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
11/30/20 RBC Capital
Sage Therapeutics price target lowered to $83 from $86 at RBC Capital
11/30/20 Piper Sandler
Piper Sandler likes Sage deal, keeps Neutral rating on Biogen
11/27/20 Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
BIIB Biogen
$240.36 /

-3.61 (-1.48%)

11/30/20 Piper Sandler
Piper Sandler likes Sage deal, keeps Neutral rating on Biogen
11/27/20 Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
11/10/20 DZ Bank
Biogen upgraded to Buy from Hold at DZ Bank
SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

Hot Stocks
UniCredit CEO Jean Pierre Mustier to retire at end of current mandate » 06:07
12/01/20
12/01
06:07
12/01/20
06:07
UNCFF

UniCredit

$0.00 /

+ (+0.00%)

UniCredit announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNCFF UniCredit
$0.00 /

+ (+0.00%)

05:18 Today Societe Generale
UniCredit downgraded to Sell from Hold at Societe Generale
05:13 Today Keefe Bruyette
UniCredit downgraded to Market Perform from Outperform at Keefe Bruyette
11/27/20 Exane BNP Paribas
UniCredit downgraded to Neutral from Outperform at Exane BNP Paribas
11/06/20 Morgan Stanley
UniCredit price target lowered to EUR 10.50 from EUR 10.80 at Morgan Stanley
UNCFF UniCredit
$0.00 /

+ (+0.00%)

Earnings
Bank of Montreal reports Q4 adj. EPS C$2.41 vs. C$2.43 last year » 06:06
12/01/20
12/01
06:06
12/01/20
06:06
BMO

Bank of Montreal

$72.67 /

-2.09 (-2.80%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$72.67 /

-2.09 (-2.80%)

BMO Bank of Montreal
$72.67 /

-2.09 (-2.80%)

11/23/20 Scotiabank
Bank of Montreal price target raised to C$104 from C$85 at Scotiabank
11/19/20 CIBC
Bank of Montreal upgraded to Outperformer from Neutral at CIBC
11/18/20 National Bank
Bank of Montreal price target raised to C$87 from C$83 at National Bank
11/12/20 Barclays
Bank of Montreal price target raised to C$80 from C$76 at Barclays
BMO Bank of Montreal
$72.67 /

-2.09 (-2.80%)

Downgrade
Vail Resorts downgraded to Market Perform from Outperform at William Blair » 06:05
12/01/20
12/01
06:05
12/01/20
06:05
MTN

Vail Resorts

$275.77 /

-5.8498 (-2.08%)

William Blair downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

11/23/20 Janney Montgomery Scott
Vail Resorts downgraded to Neutral from Buy at Janney Montgomery Scott
11/12/20 Exane BNP Paribas
Vail Resorts initiated with an Outperform at Exane BNP Paribas
10/21/20 Barclays
Vail Resorts price target raised to $254 from $235 at Barclays
09/25/20 Truist
Vail Resorts price target raised to $243 from $233 at Truist
MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

MTN Vail Resorts
$275.77 /

-5.8498 (-2.08%)

Periodicals
Apple hires venture capitalist Josh Elman for App Store role, Bloomberg reports » 06:05
12/01/20
12/01
06:05
12/01/20
06:05
AAPL

Apple

$119.06 /

+2.48 (+2.13%)

Venture capitalist Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

11/30/20
Fly Intel: Top five analyst upgrades
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/25/20 Rosenblatt
Apple taking RF front-end in-house 'highly unlikely,' says Rosenblatt
AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

Hot Stocks
AdaptHealth to acquire AeroCare Holdings for approximately $2B » 06:05
12/01/20
12/01
06:05
12/01/20
06:05
AHCO

AdaptHealth

$29.84 /

+0.16 (+0.54%)

AdaptHealth announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

11/17/20 Deutsche Bank
AdaptHealth price target raised to $36 from $26 at Deutsche Bank
11/16/20 Baird
AdaptHealth initiated with an Outperform at Baird
11/05/20 SVB Leerink
AdaptHealth price target raised to $32.50 from $23.50 at SVB Leerink
08/11/20 RBC Capital
AdaptHealth price target raised to $33 from $24 at RBC Capital
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

  • 03
    Sep
  • 01
    Jul
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

Hot Stocks
Axsome Therapeutics announces results from Phase 3 COMET trial of AXS-05 » 06:04
12/01/20
12/01
06:04
12/01/20
06:04
AXSM

Axsome Therapeutics

$72.42 /

-2.44 (-3.26%)

Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$72.42 /

-2.44 (-3.26%)

AXSM Axsome Therapeutics
$72.42 /

-2.44 (-3.26%)

09/29/20
Fly Intel: Top five analyst initiations
09/29/20 BofA
Axsome Therapeutics initiated with an Underperform at BofA
09/29/20 BofA
Axsome Therapeutics initiated with an Underperform at BofA
09/10/20 Morgan Stanley
Axsome Therapeutics initiated with an Overweight at Morgan Stanley
AXSM Axsome Therapeutics
$72.42 /

-2.44 (-3.26%)

  • 19
    Dec
AXSM Axsome Therapeutics
$72.42 /

-2.44 (-3.26%)

Initiation
Boralex initiated with a Neutral at Credit Suisse » 06:04
12/01/20
12/01
06:04
12/01/20
06:04
BRLXF

Boralex

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRLXF Boralex
$0.00 /

+ (+0.00%)

11/25/20 RBC Capital
Boralex price target raised to C$42 from C$40 at RBC Capital
11/24/20 BMO Capital
Boralex price target raised to C$43 from C$41 at BMO Capital
11/23/20 Scotiabank
Boralex price target raised to C$46.25 from C$44.50 at Scotiabank
11/23/20 BMO Capital
Boralex price target raised to C$41 from C$39 at BMO Capital
Hot Stocks
AdaptHealth to acquire AeroCare Holdings for approximately $2B  06:02
12/01/20
12/01
06:02
12/01/20
06:02
AHCO

AdaptHealth

$29.84 /

+0.16 (+0.54%)

 
ShowHide Related Items >><<
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

11/17/20 Deutsche Bank
AdaptHealth price target raised to $36 from $26 at Deutsche Bank
11/16/20 Baird
AdaptHealth initiated with an Outperform at Baird
11/05/20 SVB Leerink
AdaptHealth price target raised to $32.50 from $23.50 at SVB Leerink
08/11/20 RBC Capital
AdaptHealth price target raised to $33 from $24 at RBC Capital
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

  • 03
    Sep
  • 01
    Jul
AHCO AdaptHealth
$29.84 /

+0.16 (+0.54%)

Earnings
Amdocs and Telefonica Movistar Chile extend and expand partnership » 06:02
12/01/20
12/01
06:02
12/01/20
06:02
DOX

Amdocs

$65.76 /

-0.97 (-1.45%)

Amdocs and Telefonica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$65.76 /

-0.97 (-1.45%)

DOX Amdocs
$65.76 /

-0.97 (-1.45%)

11/11/20 JPMorgan
Amdocs upgraded to Overweight with $75 target at JPMorgan
11/11/20 JPMorgan
Amdocs upgraded to Overweight from Neutral at JPMorgan
02/05/20 Oppenheimer
Amdocs price target raised to $85 from $77 at Oppenheimer
DOX Amdocs
$65.76 /

-0.97 (-1.45%)

DOX Amdocs
$65.76 /

-0.97 (-1.45%)

DOX Amdocs
$65.76 /

-0.97 (-1.45%)

Downgrade
First Solar downgraded to Underweight ahead of 'margin cliff' at Barclays » 06:01
12/01/20
12/01
06:01
12/01/20
06:01
FSLR

First Solar

$93.44 /

-1.17 (-1.24%)

Barclays analyst Moses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$93.44 /

-1.17 (-1.24%)

FSLR First Solar
$93.44 /

-1.17 (-1.24%)

04:54 Today Barclays
First Solar downgraded to Underweight from Equal Weight at Barclays
11/10/20
Fly Intel: Top five analyst downgrades
11/10/20 Raymond James
Raymond James double downgrades First Solar to Underperform on Biden election
11/10/20 Raymond James
First Solar downgraded to Underperform from Outperform at Raymond James
FSLR First Solar
$93.44 /

-1.17 (-1.24%)

  • 17
    Sep
FSLR First Solar
$93.44 /

-1.17 (-1.24%)

FSLR First Solar
$93.44 /

-1.17 (-1.24%)

FSLR First Solar
$93.44 /

-1.17 (-1.24%)

Upgrade
Barclays upgrades FedEx on 'abundance of growth opportunities' » 05:59
12/01/20
12/01
05:59
12/01/20
05:59
FDX

FedEx

$286.57 /

-0.9 (-0.31%)

Barclays analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$286.57 /

-0.9 (-0.31%)

FDX FedEx
$286.57 /

-0.9 (-0.31%)

04:54 Today Barclays
FedEx upgraded to Overweight from Equal Weight at Barclays
10/02/20 UBS
FedEx margin runway 'long', free cash flow 'improving', says UBS
09/28/20
Fly Intel: Top five analyst upgrades
09/28/20 Deutsche Bank
Deutsche upgrades FedEx to Buy on 'very strong' pricing power
FDX FedEx
$286.57 /

-0.9 (-0.31%)

FDX FedEx
$286.57 /

-0.9 (-0.31%)

FDX FedEx
$286.57 /

-0.9 (-0.31%)

FDX FedEx
$286.57 /

-0.9 (-0.31%)

Downgrade
Barclays downgrades Appian to Underweight on 'unwarranted' 121% rally » 05:58
12/01/20
12/01
05:58
12/01/20
05:58
APPN

Appian

$140.50 /

-53.305 (-27.50%)

Barclays analyst Raimo…

Barclays analyst Raimo Lenschow downgraded Appian to Underweight from Equal Weight with an unchanged price target of $76. The 121% rally in the shares in November is driven primarily by technical factors rather than a change in fundamental narrative, Lenschow tells investors in a research note. The analyst, who says Appian is now one of the most expensive stocks in his coverage, views the rally as "unwarranted" and expects the stock to de-rate. Appian's "rich" valuation is unjustified based on its growth prospects and mix of professional services, says Lenschow.

ShowHide Related Items >><<
APPN Appian
$140.50 /

-53.305 (-27.50%)

APPN Appian
$140.50 /

-53.305 (-27.50%)

04:54 Today Barclays
Appian downgraded to Underweight from Equal Weight at Barclays
11/09/20 Truist
Appian price target raised to $95 from $52 at Truist
11/09/20 Goldman Sachs
Appian upgraded to Neutral from Sell at Goldman Sachs
11/06/20 Needham
Appian upgraded to Buy from Hold at Needham
APPN Appian
$140.50 /

-53.305 (-27.50%)

  • 29
    May
APPN Appian
$140.50 /

-53.305 (-27.50%)

APPN Appian
$140.50 /

-53.305 (-27.50%)

Hot Stocks
Amazon Web Services announces EC2 Mac instances for EC2 » 05:57
12/01/20
12/01
05:57
12/01/20
05:57
AMZN

Amazon.com

$3,169.62 /

-25.51 (-0.80%)

, AAPL

Apple

$119.06 /

+2.48 (+2.13%)

Amazon Web Services, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

11/30/20 KeyBanc
Black Friday store traffic 'the weakest in 15-plus years,' says KeyBanc
11/27/20 Truist
Amazon to claim 42c of every e-commerce dollar spent, says Truist
11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
11/27/20 DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
AAPL Apple
$119.06 /

+2.48 (+2.13%)

11/30/20
Fly Intel: Top five analyst upgrades
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/25/20 Rosenblatt
Apple taking RF front-end in-house 'highly unlikely,' says Rosenblatt
AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AMZN Amazon.com
$3,169.62 /

-25.51 (-0.80%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

Conference/Events
Morgan Stanley European economists to hold analyst/industry conference call » 05:55
12/01/20
12/01
05:55
12/01/20
05:55

Chief Cross-Asset…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Tanzanian Gold announces Stephen Mullowney as CEO » 05:54
12/01/20
12/01
05:54
12/01/20
05:54
TRX

Tanzanian Gold

$0.62 /

+ (+0.00%)

Tanzanian Gold announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRX Tanzanian Gold
$0.62 /

+ (+0.00%)

TRX Tanzanian Gold
$0.62 /

+ (+0.00%)

Hot Stocks
CSG extends partnership with Airtel Africa » 05:49
12/01/20
12/01
05:49
12/01/20
05:49
CSGS

CSG

$43.38 /

-0.3 (-0.69%)

CSG announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSGS CSG
$43.38 /

-0.3 (-0.69%)

CSGS CSG
$43.38 /

-0.3 (-0.69%)

09/10/20 B. Riley FBR
CSG pullback brings attractive entry point, says B. Riley FBR
03/10/20 Sidoti
CSG upgraded to Buy from Neutral at Sidoti
CSGS CSG
$43.38 /

-0.3 (-0.69%)

Hot Stocks
Portland General Electric, DTNA announce co-development of 'Electric Island' » 05:48
12/01/20
12/01
05:48
12/01/20
05:48
POR

Portland General Electric

$41.37 /

-1.34 (-3.14%)

, DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

Portland General Electric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POR Portland General Electric
$41.37 /

-1.34 (-3.14%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

POR Portland General Electric
$41.37 /

-1.34 (-3.14%)

11/19/20 Mizuho
Portland General Electric downgraded to Neutral from Buy at Mizuho
09/22/20 Guggenheim
Portland General Electric upgraded to Buy from Neutral at Guggenheim
09/22/20 Guggenheim
Portland General Electric upgraded to Buy from Neutral at Guggenheim
09/21/20 Mizuho
Mizuho upgrades Portland General to Buy on valuation after selloff
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

11/27/20 Exane BNP Paribas
Exane double upgrades Daimler on Mercedes electric car potential
11/27/20 Exane BNP Paribas
Daimler AG upgraded to Outperform from Underperform at Exane BNP Paribas
11/23/20 Morgan Stanley
Daimler AG price target raised to EUR 60 from EUR 58 at Morgan Stanley
11/02/20 AlphaValue
Daimler AG upgraded to Add from Sell at AlphaValue
POR Portland General Electric
$41.37 /

-1.34 (-3.14%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

POR Portland General Electric
$41.37 /

-1.34 (-3.14%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Hot Stocks
Vonage announces strategic partnership with Yameo » 05:44
12/01/20
12/01
05:44
12/01/20
05:44
VG

Vonage

$12.87 /

-0.07 (-0.54%)

Vonage has announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VG Vonage
$12.87 /

-0.07 (-0.54%)

VG Vonage
$12.87 /

-0.07 (-0.54%)

11/12/20 Citi
Citi adds Vonage to '90-day Catalyst Watch list'
10/02/20 Northland
Twilio comments positive for Kaleyra, LivePerson and Vonage, says Northland
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Morgan Stanley
Vonage downgraded to Equal Weight from Overweight at Morgan Stanley
VG Vonage
$12.87 /

-0.07 (-0.54%)

VG Vonage
$12.87 /

-0.07 (-0.54%)

Hot Stocks
iRhythm receives recommendation from NICE in digital health tech pilot » 05:42
12/01/20
12/01
05:42
12/01/20
05:42
IRTC

iRhythm

$244.17 /

+10.46 (+4.48%)

iRhythm announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$244.17 /

+10.46 (+4.48%)

IRTC iRhythm
$244.17 /

+10.46 (+4.48%)

11/17/20
Fly Intel: Top five analyst downgrades
11/17/20 Oppenheimer
iRhythm downgraded to Perform on 'crazy multiples' at Oppenheimer
11/17/20 Oppenheimer
iRhythm downgraded to Perform from Outperform at Oppenheimer
11/06/20 Canaccord
iRhythm price target raised to $273 from $236 at Canaccord
IRTC iRhythm
$244.17 /

+10.46 (+4.48%)

  • 19
    Aug
Earnings
Momo reports Q3 EPS 44c, consensus 38c » 05:39
12/01/20
12/01
05:39
12/01/20
05:39
MOMO

Momo

$14.37 /

-0.735 (-4.87%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOMO Momo
$14.37 /

-0.735 (-4.87%)

MOMO Momo
$14.37 /

-0.735 (-4.87%)

09/04/20
Fly Intel: Top five analyst initiations
09/04/20
Fly Intel: Top five analyst downgrades
09/04/20 86 Research
Momo initiated with a Buy at 86 Research
09/04/20 Morgan Stanley
Momo downgraded to Equal Weight on core business risk at Morgan Stanley
MOMO Momo
$14.37 /

-0.735 (-4.87%)

MOMO Momo
$14.37 /

-0.735 (-4.87%)

MOMO Momo
$14.37 /

-0.735 (-4.87%)

Hot Stocks
Xpeng delivers 4,224 Smart EVs in November » 05:36
12/01/20
12/01
05:36
12/01/20
05:36
XPEV

Xpeng

$58.80 /

-4.72 (-7.43%)

Xpeng announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV Xpeng
$58.80 /

-4.72 (-7.43%)

XPEV Xpeng
$58.80 /

-4.72 (-7.43%)

11/16/20 Citi
Xpeng price target raised to $57.71 from $34.70 at Citi
11/09/20 JPMorgan
Xpeng price target raised to $43 from $27 at JPMorgan
11/04/20
Fly Intel: Top five analyst initiations
11/04/20 Citi
Xpeng initiated with a Buy at Citi
XPEV Xpeng
$58.80 /

-4.72 (-7.43%)

  • 27
    Aug
XPEV Xpeng
$58.80 /

-4.72 (-7.43%)

XPEV Xpeng
$58.80 /

-4.72 (-7.43%)

Hot Stocks
Northern Trust selected by Sands Capital to provide UCITS fund administration » 05:34
12/01/20
12/01
05:34
12/01/20
05:34
NTRS

Northern Trust

$93.08 /

-2.96 (-3.08%)

Northern Trust announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTRS Northern Trust
$93.08 /

-2.96 (-3.08%)

NTRS Northern Trust
$93.08 /

-2.96 (-3.08%)

11/30/20 Morgan Stanley
Morgan Stanley upgrades Large Cap Banks & Consumer Finance to Attractive
11/11/20 Deutsche Bank
Northern Trust price target raised to $99 from $82 at Deutsche Bank
10/23/20 Citi
Northern Trust price target raised to $86 from $82 at Citi
10/22/20 RBC Capital
Northern Trust price target raised to $90 from $80 at RBC Capital
NTRS Northern Trust
$93.08 /

-2.96 (-3.08%)

Hot Stocks
Fortuna Silver Mines provides update on disputed royalty at San Jose Mine » 05:32
12/01/20
12/01
05:32
12/01/20
05:32
FSM

Fortuna Silver Mines

$6.34 /

-0.015 (-0.24%)

Fortuna Silver Mines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSM Fortuna Silver Mines
$6.34 /

-0.015 (-0.24%)

FSM Fortuna Silver Mines
$6.34 /

-0.015 (-0.24%)

11/16/20 Canaccord
Fortuna Silver Mines downgraded to Hold from Buy at Canaccord
09/16/20 CIBC
Fortuna Silver Mines price target raised to C$11.50 from C$10 at CIBC
09/11/20 National Bank
Fortuna Silver Mines price target raised to C$11 from C$10.50 at National Bank
08/28/20 PI Financial
Fortuna Silver Mines upgraded to Buy from Neutral at PI Financial
FSM Fortuna Silver Mines
$6.34 /

-0.015 (-0.24%)

FSM Fortuna Silver Mines
$6.34 /

-0.015 (-0.24%)

FSM Fortuna Silver Mines
$6.34 /

-0.015 (-0.24%)

Downgrade
Repsol downgraded to Sector Perform from Outperform at RBC Capital » 05:29
12/01/20
12/01
05:29
12/01/20
05:29
REPYY

Repsol

$0.00 /

+ (+0.00%)

RBC Capital analyst Biraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REPYY Repsol
$0.00 /

+ (+0.00%)

11/30/20 Berenberg
Repsol price target raised to EUR 9 from EUR 8 at Berenberg
11/17/20 Berenberg
Repsol price target lowered to EUR 8 from EUR 8.50 at Berenberg
11/13/20 Credit Suisse
Repsol downgraded to Underperform from Outperform at Credit Suisse
10/30/20 Barclays
Repsol price target lowered to EUR 7.50 from EUR 10 at Barclays

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.